IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment

Thursday, June 2, 2011 General News
Email Print This Page Comment
Font : A-A+

IDE Study Examines Performance of SUPERA® Stent in Superficial Femoral Artery (SFA)

Contact:

Donna Lucchesi

Vice President Global Marketing

IDEV Technologies, Incorporated

(281) 525-2000



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook